blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0572549

EP0572549 - USE OF TOPOTECAN IN THE TREATMENT OF NON-SMALL CELL LUNG CARCINOMA [Right-click to bookmark this link]
Former [1993/49]TREATMENT OF NON-SMALL CELL LUNG CARCINOMA
[2002/01]
StatusNo opposition filed within time limit
Status updated on  26.09.2003
Database last updated on 19.07.2024
Most recent event   Tooltip26.09.2003No opposition filed within time limitpublished on 12.11.2003  [2003/46]
Applicant(s)For all designated states
SMITHKLINE BEECHAM CORPORATION
One Franklin Plaza, P.O. Box 7929 Philadelphia
Pennsylvania 19101 / US
[N/P]
Former [2002/51]For all designated states
SmithKline Beecham Corporation
One Franklin Plaza, P.O. Box 7929
Philadelphia, Pennsylvania 19101 / US
Former [1994/40]For all designated states
SMITHKLINE BEECHAM CORPORATION
UW2220, 709 Swedeland Road, P.O. Box 1539
King of Prussia, PA 19406-0939 / US
Former [1993/49]For all designated states
SMITHKLINE BEECHAM CORPORATION
709 Swedeland Road, P.O. Box 1539
King of Prussia, PA 19406-0939 / US
Inventor(s)01 / JOHNSON, Randall, Keith c/o GlaxoSmithKline
709 Swedeland Road,P.O.Box 1539
King of Prussia, PA 19406 / US
 [2002/31]
Former [1993/49]01 / JOHNSON, Randall, Keith
71 Llanfiar Circle
Ardmore, Pennsylvania 19003 / US
Representative(s)Waters, David Martin, et al
GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road Brentford
Middlesex TW8 9GS / GB
[N/P]
Former [2001/51]Waters, David Martin, et al
GlaxoSmithKline, Corporate Intellectual Property, Two New Horizons Court
Brentford, Middlesex TW8 9EP / GB
Former [1993/49]Tocher, Pauline, et al
SmithKline Beecham plc Corporate Intellectual Property SB House Great West Road
Brentford, Middlesex TW8 9BD / GB
Application number, filing date92907467.207.02.1992
[1993/49]
WO1992US01034
Priority number, dateUS1991065893721.02.1991         Original published format: US 658937
[1993/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9214471
Date:03.09.1992
Language:EN
[1992/23]
Type: A1 Application with search report 
No.:EP0572549
Date:08.12.1993
Language:EN
The application published by WIPO in one of the EPO official languages on 03.09.1992 takes the place of the publication of the European patent application.
[1993/49]
Type: B1 Patent specification 
No.:EP0572549
Date:20.11.2002
Language:EN
[2002/47]
Search report(s)International search report - published on:US03.09.1992
(Supplementary) European search report - dispatched on:EP25.11.1993
ClassificationIPC:A61K31/535, A61K31/495, A61K31/44, A61K31/47
[1994/02]
CPC:
A61K31/4745 (EP,US); A61K31/535 (EP,KR,US); A61K31/47 (EP,US);
A61K31/495 (EP,US); A61K31/496 (EP,US); A61K31/5377 (EP,US);
A61P35/00 (EP) (-)
Former IPC [1993/49]A61K31/535, A61K31/495, A61K31/44
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   MC,   NL,   SE [1993/49]
TitleGerman:VERWENDUNG VON TOPOTECAN IN DER BEHANDLUNG VON NICHTKLEINZELLIGEN LUNGENKARZINOMEN[2002/01]
English:USE OF TOPOTECAN IN THE TREATMENT OF NON-SMALL CELL LUNG CARCINOMA[2002/01]
French:UTILISATION DE TOPOTECAN DANS LE TRAITEMENT DES CANCERS DU POUMON AUTRES QUE DU TYPE A PETITES CELLULES[2002/01]
Former [1993/49]BEHANDLUNG VON NICHTKLEINZELLIGEN LUNGENKARZINOMEN
Former [1993/49]TREATMENT OF NON-SMALL CELL LUNG CARCINOMA
Former [1993/49]TRAITEMENT DES CANCERS DU POUMON AUTRES QU'A PETITES CELLULES
Entry into regional phase23.08.1993National basic fee paid 
23.08.1993Search fee paid 
23.08.1993Designation fee(s) paid 
23.08.1993Examination fee paid 
Examination procedure17.09.1992Request for preliminary examination filed
International Preliminary Examining Authority: DE
23.08.1993Examination requested  [1993/49]
19.01.1999Despatch of a communication from the examining division (Time limit: M04)
06.05.1999Reply to a communication from the examining division
22.11.1999Despatch of a communication from the examining division (Time limit: M04)
09.05.2000Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
19.07.2000Reply to a communication from the examining division
24.10.2001Date of oral proceedings
29.11.2001Despatch of communication of intention to grant (Approval: Yes)
29.11.2001Minutes of oral proceedings despatched
14.06.2002Communication of intention to grant the patent
11.09.2002Fee for grant paid
11.09.2002Fee for publishing/printing paid
Opposition(s)21.08.2003No opposition filed within time limit [2003/46]
Request for further processing for:18.07.2000Request for further processing filed
18.07.2000Full payment received (date of receipt of payment)
Request granted
02.08.2000Decision despatched
Fees paidRenewal fee
31.01.1994Renewal fee patent year 03
15.02.1995Renewal fee patent year 04
05.02.1996Renewal fee patent year 05
07.02.1997Renewal fee patent year 06
11.02.1998Renewal fee patent year 07
08.02.1999Renewal fee patent year 08
10.02.2000Renewal fee patent year 09
05.02.2001Renewal fee patent year 10
04.02.2002Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[DA]EP0321122  (SMITHKLINE BECKMAN CORP [US])
 [X]  - H. BURRIS ET AL, "SKF 104864: preclinical studies of a new topoisomerase I inhibitor.", PROC. AM. ASSOC. CANCER RES. ANNU. MEET., (1990), vol. 31, page 431 [X] 1 * abstract #2558 *
 [A]  - M.R. MATTERN ET AL, "Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor SKF 104864", PROC. AM. ASSOC. CANCER RES. ANNU. MEET., (1990), vol. 31, page 436 [A] * abstract #2587 *
International search[XP]US5004758  (BOEHM JEFFREY C [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.